InsidersTradesSigma
NewAmsterdam Pharma Co N.V. Stock: price and management transactions · United States · SEC (Form 4)
SEC:newamsterdam-pharma-co-nv-ae54beUS·SEC (Form 4)
Follow the NewAmsterdam Pharma Co N.V. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was disclosed on 24 June 2026 (Levée d'options). Among the most active insiders: Kling Douglas F. All data is openly available.
58
Insider Decl.
n/a
Thresholds
€723,215
10 ops.
Buy Volume
€14m
11 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 June 2026
Declarations58 total
25,000 sharesOrdinary SharesSEC:0001193125-26-281062:0
15,000 sharesOrdinary SharesSEC:0001193125-26-281062:1
39,700 sharesOrdinary SharesSEC:0001193125-26-281062:2
300 sharesOrdinary SharesSEC:0001193125-26-281062:3
471 shares@ US$23.9787Ordinary SharesSEC:0001415889-25-021660:0
Canonical exit: 9 Nov 2025 (T+90)
47,569 shares@ US$10.9015.4% of flowOrdinary SharesSEC:0000950170-25-096665:0
2,520 shares@ US$18.43438.8% of flowOrdinary SharesSEC:0001415889-25-018316:0
Canonical exit: 22 Sept 2025 (T+90)
8,584 shares@ US$19.499234.8% of flowOrdinary SharesSEC:0001415889-25-017693:0
Canonical exit: 14 Sept 2025 (T+90)
78,101 shares@ US$10.0027.5% of flowOrdinary SharesSEC:0000950170-25-087937:0
55,000 sharesOrdinary SharesSEC:0000950170-25-081087:0
68 shares0Ordinary SharesSEC:0000950170-25-081072:0
100,000 shares@ US$10.0050.2% of flowOrdinary SharesSEC:0000950170-25-074463:0
69 shares0Ordinary SharesSEC:0000950170-25-062894:0
69 shares0Ordinary SharesSEC:0000950170-25-056395:0
100,000 shares@ US$10.0049.8% of flowOrdinary SharesSEC:0000950170-25-055612:0
10,860 sharesOrdinary SharesSEC:0000950170-25-055603:0
16,539 shares0Ordinary SharesSEC:0000950170-25-046943:0
3,102 shares0Ordinary SharesSEC:0000950170-25-046958:0
1,135 shares@ US$22.48518.7% of flowOrdinary SharesSEC:0001415889-25-009198:0
Canonical exit: 24 Jun 2025 (T+90)
30,992 shares0Ordinary SharesSEC:0000950170-25-046934:0
8,269 shares0Ordinary SharesSEC:0000950170-25-046962:0
19,302 shares0Ordinary SharesSEC:0000950170-25-046947:0
150,000 sharesOrdinary SharesSEC:0000950170-25-045283:0
88,112 sharesOrdinary SharesSEC:0000950170-25-042176:0
4,005 shares@ US$21.024529.6% of flowOrdinary SharesSEC:0001415889-25-007263:0
Canonical exit: 2 Jun 2025 (T+90)
25 of 58 declarations
About NewAmsterdam Pharma Co N.V.
NewAmsterdam Pharma Co N.V. is a biopharmaceutical company focused on developing innovative treatments for metabolic diseases. It is listed on NASDAQ under the ticker NAMS.